FcγR3A polymorphism influences natural killer cell activation and response to anti-PD-L1 (avelumab) in gestational trophoblastic neoplasia.
Msika A, Mathias V, Boudigou M, Chambon M, Dubois V, Hajri T, Lotz JP, Massardier J, Descargues P, Gladieff L, Joly F, Lebreton C, Maucort-Boulch D, Bin S, Rousset P, Allias F, Gaillot-Durand L, Devouassoux-Shisheboran M, Lemaitre N, Alfaidy N, Langlois-Jacques C, Alves-Ferreira M, Golfier F, You B, Thaunat O, Bolze PA, Koenig A.
Msika A, et al.
Am J Obstet Gynecol. 2024 Oct 5:S0002-9378(24)01046-9. doi: 10.1016/j.ajog.2024.09.115. Online ahead of print.
Am J Obstet Gynecol. 2024.
PMID: 39370035
Free article.